Search clinical trials for: Non-Alcoholic Steatohepatitis

Total 905 results

Ali Aminian

Not yet recruiting

Fibrosis Lessens After Metabolic Surgery (FLAMES)

Obesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)

United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
Boehringer Ingelheim

Recruiting

A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight

Obesity | Non-Alcoholic SteatoHepatitis (NASH)

United States
Michael Ohliger, MD PhD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease

NAFLD | Non-Alcoholic Fatty Liver Disease | NASH | Non Alcoholic Fatty Liver | Non Alcoholic Steatohepatitis

United States
Haisco Pharmaceutical Group Co., Ltd.

Recruiting

To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .

Non-Alcoholic Steatohepatitis (NASH)

China
Pichamol Jirapinyo, MD, MPH

Not yet recruiting

ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial

Liver Diseases | Metabolic Diseases | Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Insulin Resistance | Weight Loss | Liver Fat | NAFLD | Insulin Sensitivity/Resistance | Insulin Sensitivity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non Alcoholic Fatty... and other conditions

United States
Altimmune, Inc.

Recruiting

Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) (IMPACT Trial) (IMPACT)

Non-Alcoholic Steatohepatitis (NASH)

Australia, United States, Puerto Rico
Rivus Pharmaceuticals, Inc.

Recruiting

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

Fatty Liver | Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis (SYNCH)

Probiotics | Non-Alcoholic Fatty Liver Disease | Microbiome | Gut Microbiome | Fecal Microbiota Transplantation | Intestinal Microbiome | FMT | Non Alcoholic Steatohepatitis | Prebiotics

Netherlands
Dr Adnan Agha

Recruiting

Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue

Liver Fat | Type 2 Diabetes | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

United Arab Emirates
Tanta University

Not yet recruiting

Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis
Brigham and Women's Hospital

Recruiting

Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease

Obesity | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

United States
Institut National de la Santé Et de la Recherche...
Centre Hospitalier Universitaire de Nice

Not yet recruiting

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome (CHALNA2)

Hepatocellular Carcinoma | Cirrhosis, Liver | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Alcohol-related Liver Disease
McMaster University
Canadian Institutes of Health Research (CIHR)

Recruiting

Soluble Fibre Supplementation in NAFLD (FIND)

Hepatic Steatosis | Non-Alcoholic Fatty Liver Disease | Non Alcoholic Steatohepatitis

Canada
Dana-Farber Cancer Institute

Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Lung Cancer | Cirrhosis | Barrett Esophagus | Hematologic Malignancy | Non-Alcoholic Fatty Liver Disease | Cancer Risk | Vulvar Intraepithelial Neoplasia | Childhood Cancer Survivors | Lung; Node | Non Alcoholic Steatohepatitis | Osteochondroma | Cancer Predisposition Syndrome | Hereditary Cancer Prediction | Adult... and other conditions

United States
Eli Lilly and Company

Recruiting

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Nonalcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease

United States, Japan
National Research Centre, Egypt

Not yet recruiting

Omics-based Predictors of NAFLD/Potential NASH

Non-Alcoholic Fatty Liver Disease | Non Alcoholic Steatohepatitis

Egypt
E-Scopics

Not yet recruiting

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH (POCUS-NASH)

Liver Diseases | Liver Cirrhosis | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease | Steatosis of Liver
Hacettepe University

Recruiting

The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis

Non-Alcoholic Steatohepatitis

Turkey
Madrigal Pharmaceuticals, Inc.

Recruiting

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Non-Alcoholic Fatty Liver Disease

United States, Puerto Rico
Azienda Unità Sanitaria Locale Reggio Emilia

Recruiting

Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients (ImagingNAFLD)

Steatohepatitis, Nonalcoholic | Non-Alcoholic Fatty Liver Disease | Liver Fibroses

Italy
Maastricht University Medical Center

Not yet recruiting

Plant Stanols and Liver Inflammation in Overweight and Obese Children

Pediatric Obesity | Childhood Obesity | NAFLD | NASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | NASH | Childhood Overweight

Netherlands
Institut National de la Santé Et de la Recherche...

Not yet recruiting

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". (LivMOD)

Viral Hepatitis C | Liver Cancer | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Chronic Liver Disease and Cirrhosis | Viral Hepatitis B | Viral Hepatitis D
Manchester University NHS Foundation Trust
University of Nottingham; University of Manchester; Innovate UK

Recruiting

Integrated Diagnostics for Early Diagnosis of Liver Disease (ID LIVER)

Alcoholic Liver Disease | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Liver Fibroses

United Kingdom
Philips Clinical & Medical Affairs Global

Recruiting

Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study (LFQ)

Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis

United States
National Taiwan University Hospital
Ministry of Science and Technology, Taiwan

Recruiting

Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric Surgery

Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Bariatric Surgery

Taiwan
Mayo Clinic

Recruiting

The Olmsted NAFLD Epidemiology Study (TONES)

Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis

United States
Medical College of Wisconsin
ENDRA Life Sciences, Inc.

Recruiting

Assessment of Fatty Liver With Thermo-acoustic Device

Fatty Liver | NAFLD | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non-alcoholic Fatty Liver | NASH | Fatty Liver Disease

United States
Cambridge University Hospitals NHS Foundation Trust
The European Association for the Study of the Liver; Children's Liver Disease...

Recruiting

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD) (EU-PNAFLD)

Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non-alcoholic Fatty Liver

United Kingdom, Netherlands
Cirius Therapeutics, Inc.

Not yet recruiting

A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH

Type2 Diabetes | Nonalcoholic Steatohepatitis | NASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease
National Institute of Diabetes and Digestive and...
National Cancer Institute (NCI)

Recruiting

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis

United States
Puerta de Hierro University Hospital
Hospital Universitario Marqués de Valdecilla

Not yet recruiting

Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic Steatohepatitis (FMT-NASH)

Non-Alcoholic Fatty Liver Disease | Non Alcoholic Steatohepatitis

Spain
Perspectum

Recruiting

Repeatability and Reproducibility of Multiparametric MRI

Liver Diseases | Cirrhosis | Primary Sclerosing Cholangitis | Autoimmune Hepatitis | Hemochromatosis | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Primary Biliary Cirrhosis | Viral Hepatitis

Netherlands, United Kingdom
Hospital of South West Jutland
Odense University Hospital; University of Southern Denmark

Recruiting

Prognostic Significance of Fatty Liver Disease in Bariatric Patients (PROMETHEUS)

Obesity, Morbid | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Metabolic Encephalopathy

Denmark
Humanity and Health Research Centre
Beijing 302 Hospital

Recruiting

Nonalcoholic Steatohepatitis in Chinese Children

Non-Alcoholic Fatty Liver Disease

China
Humanity and Health Research Centre

Recruiting

Longitudinal Observational Study Of Chinese With NAFLD/NASH

Non-Alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steatohepatitis (NASH)

Hong Kong
State University of New York at Buffalo

Recruiting

Blood Collection Biorepository for Liver Disease Research

Fibrosis | Hepatitis B | Hepatitis C | Fatty Liver | Cirrhosis | Bariatric Surgery Candidate | Obesity, Childhood | Non-Alcoholic Steatohepatitis(NASH)

United States
National Institute of Diabetes and Digestive and...

Completed

Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease

Fatty Liver | Liver Disease

United States
University of Oxford

Active, not recruiting

MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH) (MRI-Detect)

Non-Alcoholic Fatty Liver Disease

United Kingdom
Ionis Pharmaceuticals, Inc.

Completed

A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224

Steatohepatitis, Nonalcoholic

United States, Puerto Rico
Oramed, Ltd.
Hadassah Medical Organization

Completed

A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)

Type2 Diabetes Mellitus | Non-Alcoholic Steatohepatitis (NASH)

Israel
Sunshine Lake Pharma Co., Ltd.

Completed

A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis

Non-Alcoholic Steatohepatitis

China
Zydus Therapeutics Inc.

Completed

Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis (EVIDENCES IV)

Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease

United States
University of Wisconsin, Madison
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); GE... and other collaborators

Active, not recruiting

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD (NAFLD)

Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

United States
University of Pittsburgh

Completed

Integrated Approaches for Identifying Molecular Targets in Liver Disease (InLi)

Steatohepatitis, Nonalcoholic | Alcoholic Liver Disease | Non-Alcoholic Fatty Liver Disease | Steatohepatitis

United States
Madrigal Pharmaceuticals, Inc.

Completed

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients (MAESTRO-NAFLD1)

Non-Alcoholic Fatty Liver Disease

United States, Puerto Rico
University of California, Davis

Completed

Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER (EXPLORER)

Nonalcoholic Steatohepatitis (NASH) | Non-Alcoholic Fatty Liver Disease (NAFLD)

United States
University Hospital for Infectious Diseases, Croatia
Croatian Science Foundation

Completed

The Role of Immune Semaphorins in NAFLD (SepsisFAT)

Immune Response | Biomarkers | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Non Alcoholic Steatohepatitis

Croatia
Inventiva Pharma

Completed

Phase 2b Study in NASH to Assess IVA337 (NATIVE)

Non-Alcoholic Steatohepatitis (NASH)

United States, Spain, United Kingdom, France, Belgium, Austria, Switzerland, Australia, Germany, Slovenia, Bulgaria, Canada, Czechia, Italy, Mauritius, Poland
Universidade Federal do Paraná

Active, not recruiting

Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD). (NUTRINAFLD)

Liver Diseases | Steatosis | Steatohepatitis, Nonalcoholic | Steatohepatitis

Brazil
Celgene

Terminated

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Liver Cirrhosis | Non-alcoholic Fatty Liver Disease

United States, Spain, Australia, Korea, Republic of, Canada, Germany, France, Japan, United Kingdom, Poland

Search clinical trials for: Non-Alcoholic Steatohepatitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations